Fundraising Fox

Metyos

Paris, FR · 18 employees on LinkedIn · 1 known investors

Metyos is developing a wearable medical device for continuous potassium monitoring to support the management of chronic diseases. It targets doctors and health professionals treating complex pathologies by providing continuous biological data on patients' physiological states.

Deep TechDigital HealthHardwareMedical Devices

Founders & leadership

A
Alex
O
Olga

Investors · 1

Kima VenturesParis · $50K – $5M

Funding

SEC filings, press & company announcements

$2.3M disclosed across 1 of 2 rounds · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Startup building 'biowearables' for chronic kidney disease nets €2.3Mthenextweb.com · Mar 2024French biowearable startup Metyos raises €2.3M in pre-Seed funding: Know more - Silicon Canalssiliconcanals.com · Mar 2024Paris-based medtech Metyos snaps €2.3 million to improve the lives of millions of chronic kidney disease patients | EU-Startupseu-startups.com · Mar 2024Metyos has developed a wearable to monitor chronic kidney disease. Check out the 8-slide pitch deck it used to raise $2.5 million.businessinsider.com · Mar 2024Metyos Raises €2.3M in Pre-Seed Fundingfinsmes.com · Mar 2024Metyos raises €2.3M pre-seed to combat chronic kidney disease - Tech.eutech.eu · Mar 2024

Frequently asked questions

What does Metyos do?
Metyos is developing a wearable medical device for continuous potassium monitoring to support the management of chronic diseases. It targets doctors and health professionals treating complex pathologies by providing continuous biological data on patients' physiological states.
Who are Metyos's investors?
Metyos's investors include Kima Ventures.
How much funding has Metyos raised?
Metyos has disclosed $2.3M raised across 1 of its 2 known rounds.
Where is Metyos headquartered?
Metyos is headquartered in Paris, FR.